Marina F Fahmy, MD

2 in Phase 3

Quick facts

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Marina F Fahmy, MD

What is Marina F Fahmy, MD's pipeline?

Marina F Fahmy, MD has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include ACTIVA KIDS bioactive restorative material, Fuji IX EXTRA.

Related